These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4355246

  • 1. Induction of immunity in man by crystalline adenovirus type 5 capsid antigens.
    Couch RB, Kasel JA, Perreira HG, Haase AT, Knight V.
    Proc Soc Exp Biol Med; 1973 Sep; 143(4):905-10. PubMed ID: 4355246
    [No Abstract] [Full Text] [Related]

  • 2. Immunization of cattle with apolyvalent bovine adenovirus vaccine.
    Bartha A.
    Dev Biol Stand; 1974 Sep; 26():15-8. PubMed ID: 4373297
    [No Abstract] [Full Text] [Related]

  • 3. IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.
    KASEL JA, HUBER M, LODA F, BANKS PA, KNIGHT V.
    Proc Soc Exp Biol Med; 1964 Oct; 117():186-90. PubMed ID: 14219941
    [No Abstract] [Full Text] [Related]

  • 4. Specific humoral immunity among volunteers with experimental adenovirus infection.
    Selivanov AA, Kovaleva TP, Smorodintsev AA.
    Arch Gesamte Virusforsch; 1972 Oct; 36(1):36-42. PubMed ID: 4335024
    [No Abstract] [Full Text] [Related]

  • 5. [Successive multiple immunization with adenoviruses].
    Wigand R, Kho JT.
    Z Med Mikrobiol Immunol; 1970 Oct; 156(1):115-24. PubMed ID: 4320671
    [No Abstract] [Full Text] [Related]

  • 6. Adenovirus neutralization--behavior of virion derived capsid components in the production of in vitro neutralizing antibody.
    Shortridge KF.
    Microbios; 1972 Oct; 5(20):265-72. PubMed ID: 4673679
    [No Abstract] [Full Text] [Related]

  • 7. Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.
    Smith TJ, Buescher EL, Top FH, Altemeier WA, McCown JM.
    J Infect Dis; 1970 Oct; 122(4):239-48. PubMed ID: 4323443
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM, Mogabgab WJ.
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J, Abarbanel MF, Oei KG.
    Antonie Van Leeuwenhoek; 1969 Dec; 35(2):239. PubMed ID: 4316421
    [No Abstract] [Full Text] [Related]

  • 10. Sensitization and neutralization of adenovirus by specific sera against capsid subunits.
    Wadell G.
    J Immunol; 1972 Mar; 108(3):622-32. PubMed ID: 4110982
    [No Abstract] [Full Text] [Related]

  • 11. Antigenic comparisons and serologic survey of equine adenoviruses.
    Studdert MJ, Wilks CR, Coggins L.
    Am J Vet Res; 1974 May; 35(5):693-9. PubMed ID: 4364459
    [No Abstract] [Full Text] [Related]

  • 12. Serological identification of an Australian adenovirus isolate from sheep.
    Adair BM, McKillop ER, Coackley BH.
    Aust Vet J; 1986 May; 63(5):162. PubMed ID: 3019292
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isolation of an adenovirus from the brain of a pig.
    Kasza L.
    Am J Vet Res; 1966 May; 27(118):751-8. PubMed ID: 4289789
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Naturally occurring infection of calves with a bovine adenovirus.
    Mattson DE.
    Am J Vet Res; 1973 May; 34(5):623-9. PubMed ID: 4349986
    [No Abstract] [Full Text] [Related]

  • 18. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J, Abarbanel MF, Oei KG.
    J Hyg (Lond); 1968 Dec; 66(4):499-511. PubMed ID: 4303951
    [No Abstract] [Full Text] [Related]

  • 19. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.
    Chanock RM, Ludwig W, Heubner RJ, Cate TR, Chu LW.
    JAMA; 1966 Feb 07; 195(6):445-52. PubMed ID: 4296283
    [No Abstract] [Full Text] [Related]

  • 20. Epidemic keratoconjunctivitis. A severe industrial outbreak due to adenovirus type 8.
    Sprague JB, Hierholzer JC, Currier RW, Hattwick MA, Smith MD.
    N Engl J Med; 1973 Dec 20; 289(25):1341-6. PubMed ID: 4356635
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.